<i>TP53</i> and Decitabine in Acute Myeloid Leukemia and Myelodysplastic SyndromesJohn S. Welch, Timothy J. Ley, Yi-Shan Lee et al.|New England Journal of Medicine|2016Cited by 783
Multidimensional Analyses of Donor Memory-Like NK Cells Reveal New Associations with Response after Adoptive Immunotherapy for LeukemiaMelissa M. Berrien-Elliott, Todd A. Fehniger, Amanda F. Cashen et al.|Cancer Discovery|2020Cited by 146
Mutation Clearance after Transplantation for Myelodysplastic SyndromeEric J. Duncavage, Matthew J. Walter, Meagan A. Jacoby et al.|New England Journal of Medicine|2018Cited by 121
Protective Effect of Cytomegalovirus Reactivation on Relapse after Allogeneic Hematopoietic Cell Transplantation in Acute Myeloid Leukemia Patients Is Influenced by Conditioning RegimenShivaprasad Manjappa, Rizwan Romee, Pavan Kumar Bhamidipati et al.|Biology of Blood and Marrow Transplantation|2013Cited by 97
Impact of a 40-Gene Targeted Panel Test on Physician Decision Making for Patients With Acute Myeloid LeukemiaErica K. Barnell, Obi L. Griffith, Kenneth F. Newcomer et al.|JCO Precision Oncology|2021Cited by 9